CyclooxygenaseMay 2001 Molecule of the Month by David Goodsell
doi: 10.2210/rcsb_pdb/mom_2001_5 (PDF Version, ePub Version )
A Wonder Drug
What is the most commonly-taken drug today? It is an effective painkiller. It reduces fever and inflammation when the body gets overzealous in its defenses against infection and damage. It slows blood clotting, reducing the chance of stroke and heart attack in susceptible individuals. And, there is growing evidence that it is an effective addition to the fight against cancer. This wonder drug, with manifold uses in medicine, is aspirin. Aspirin has been used professionally for a century, and traditionally since ancient times. A similar compound found in willow bark, salicylic acid, has a long history of use in herbal treatment. But only in the last few decades have we understood how aspirin works, and how it might be improved.
As you might expect from a drug with such diverse actions, aspirin blocks a central process in the body. Aspirin blocks the production of prostaglandins, key hormones that are used to carry local messages. Unlike most hormones, which are produced in specialized glands and then delivered throughout the body by the blood, prostaglandins are created by cells and then act only in the surrounding area before they are broken down. Prostaglandins control many of these neighborhood processes, including the constriction of muscle cells around blood vessels, aggregation of platelets during blood clotting, and constriction of the uterus during labor. Prostaglandins also deliver and strengthen pain signals and induce inflammation. These many different processes are all controlled by different prostaglandins, but all created from a common precursor molecule.
Cyclooxygenase (shown here from PDB entry 1prh) performs the first step in the creation of prostaglandins from a common fatty acid, as shown in the box. It adds two oxygen molecules to arachidonic acid, beginning a set of reactions that will ultimately create a host of unusual molecules. Aspirin blocks the binding of arachidonic acid in the cyclooxygenase active site. The normal messages are not delivered, so we don't feel the pain and don't launch an inflammation response.
COX-1 and COX-2
We actually build two different cyclooxygenases (termed COX-1 and COX-2) for different purposes. COX-1 is built in many different cells to create prostaglandins used for basic housekeeping messages throughout the body. The second enzyme is built only in special cells and is used for signaling pain and inflammation. Unfortunately, aspirin attacks both. Since COX-1 is targeted, aspirin can lead to unpleasant complications, such as stomach bleeding. Fortunately, specific compounds that block just COX-2, leaving COX-1 to perform its essential jobs, are now becoming available. These new drugs are selective pain-killers and fever reducers, without the unpleasant side-effects.
A Complex Enzyme
This enzyme actually has two different active sites, collectively termed prostaglandin synthase. On one side, it has the cyclooxygenase active site discussed on the previous page. On the opposite side, is has an entirely separate peroxidase site, which is needed to activate the heme groups that participate in the cyclooxygenase reaction. The enzyme complex is a dimer of identical subunits, so altogether, there are two cyclooxygenase active sites and two peroxidase active sites in close proximity. Each subunit has a knob covered with hydrophobic amino acids, pointing downward in this illustration. These knobs anchor the complex to the membrane of the endoplasmic reticulum, shown in light blue at the bottom of the picture. The cyclooxygenase active site is buried deep within the protein, and is reachable by a tunnel that opens out in the middle of the knob. This acts like a funnel, guiding arachidonic acid out of the membrane and into the enzyme for processing. In the structure shown here, PDB entry 4cox, a drug (yellow and green) is blocking the active site in both subunits. The heme groups are also shown above the drug in each subunit.
Exploring the Structure
PDB entry 1pth shows how aspirin blocks the cyclooxygenase active site. Aspirin is composed of two parts: an acetyl group attached to salicylic acid. When it attacks cyclooxygenase, it connects its acetyl group to a serine amino acid, permanently inactivating the enzyme. The picture shown here is a close-up of the active site after aspirin has performed its job. The acetyl group (shown in white and red) is attached to the serine amino acid (bright green), and the salicylic acid (large spheres) is bound close by. The backbone of the protein is shown in dark green.
This illustration was created with RasMol. You can create similar pictures by clicking on the PDB accession code above and picking one of the options under View Structure. Note that this structure includes only one of the two subunits, so when you look at the structure, you will be looking at only half of the entire complex. Also, a modified form of aspirin, with a bromine atom attached, was used in this structure; the bromine atom is not shown in this picture.
More Information on Cyclooxygenase
Lawrence J. Marnett, Scott W. Rowlinson, Douglas C. Goodwin, Amit S. Kalgutkar and Cheryl A. Lanzo (1999) Arachidonic Acid Oxygenation by COX-1 and COX-2. Journal of Biological Chemistry 274, 22903-22906.
William L. Smith, R. Michael Garavito and David L. DeWitt (1996) Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and -2. Journal of Biological Chemistry 271, 33157-33160.
© 2013 David Goodsell & RCSB Protein Data Bank